Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2022 Apr 6;74(7):1188–1195. doi: 10.1002/acr.24545

Table 1:

Demographics and Features of the IgG4-Related Disease Cohort

Overall
N 231
Age at Diagnosis (mean, SD) 59.5 (13.7)
Male (N, %) 150 (65%)
Race
 White 173 (75%)
 Asian 32 (14%)
 Black 10 (4%)
 Native-American 1 (<1%)
 Unknown / Other 15 (6%)
Ethnicity
 Non-Hispanic 185 (80%)
 Hispanic 29 (13%)
 Unknown / Other 17 (7%)
Selected Organ Involvement
 Head and Neck 137 (59%)
  Dacryo- or Sialoadenitis 113 (49%)
   Lacrimal glands 50 (22%)
   Salivary glands 98 (42%)
  Orbital (non-lacrimal) 34 (15%)
  Other head and neck 109 (47%)
 Lymph nodes 63 (27%)
 Pulmonary 44 (19%)
 Aorta 21 (9%)
 Retroperitoneum 41 (18%)
 Pancreato-hepatobiliary 78 (34%)
 Renal 47 (20%)
Laboratory Results (median, IQR)
 IgG4 Concentration (n=228) 142.4 (53.2, 390.8)
  % Ever Elevated^ 168 (73%)
 Eosinophil Concentration (n=193) 0.20 (0.10, 0.40)
  % Elevated^ 40 (21%)
 IgE Concentration (n=192) 104.0 (25.0, 284.5)
  % Elevated^ 98 (51%)
 Erythrocyte Sedimentation Rate (n=159) 24.0 (10.0, 45.0)
  % Elevated^ 66 (42%)
 C-Reactive Protein (n=161) 3.8 (1.3, 9.1)
  % Elevated^ 53 (33%)
 C3 (n=191) 115.0 (85.0, 145.0)
  % Low C3 23 (12%)
 C4 (n=193) 23.0 (12.0, 31.0)
  % Low C4 32 (17%)
^

Elevated refers to serum IgG4 concentration > the assay’s upper limit of normal, serum IgE concentration ≥ 100 IU/mL, eosinophils ≥ 0.5 109/L, ESR > 30 mm/hr, and CRP > 7 mg/L